Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Octapharma Names Dennis D. Curtin To Lead U.S. Plasma Operations

By Pharmaceutical Processing | December 5, 2008

Octapharma Chairman Wolfgang Marguerre has announced that Dennis D. Curtin has been selected to lead Octapharma’s plasma operations in the United States. Curtin had been Octapharma’s U.S. legal counsel since 2002 and will now serve as President of Life Therapeutics, Inc. The largest private plasma products company in the world, Octapharma recently acquired Life Therapeutics, the Atlanta company that operates 12 plasma centers in the U.S. with approximately 300 employees. Octapharma’s business plan is to own and operate approximately 50 plasma centers in the U.S. with a projected 1,500 employees. Curtin will also be responsible for Octapharma’s recovered plasma program operated in conjunction with Group Services for America’s Blood Centers and Octapharma’s source plasma contracts with independent plasma suppliers in the United States. “We are very pleased to officially welcome Dennis Curtin to Octapharma’s leadership team,” said Octapharma Chairman Wolfgang Marguerre. “Dennis has been a vital asset as our external U.S. legal counsel and his extensive knowledge of the plasma industry will be invaluable as we move forward with plans to grow our recovered and source plasma network, and product portfolio, in the U.S.” With more than 25 years of legal experience, Curtin had been in private practice with the Plattsburgh, N.Y. law firm of Stafford, Owens, Curtin & Trombley, PLLC. He graduated from Union College (B.S., 1978), New England School of Law (J.D., 1982) and Georgetown University (LLM, 1986). “I am looking forward to my new role at Octapharma and helping the company achieve its goal of fulfilling patient needs around the globe,” Curtin said. “Octapharma’s therapies for the treatment of coagulation disorders and immune diseases, and its intensive care and emergency care products, are in very high demand in the U.S. and internationally. Our goal is to source approximately 50 percent of the plasma needed for our products from Octapharma-owned plasma centers in the U.S. and Europe by the next decade to ensure patient needs are met.” In August, Octapharma announced plans to acquire 33 plasma collection centers from International BioResources. The plasma centers will be located predominantly in the East and Midwest. Plasma is the source of numerous proteins used for drug development and therapeutic purposes. These proteins include albumin, clotting factors, and intravenous immunoglobulin (IVIG). Source plasma is collected by plasmapheresis and intended for further manufacturing; recovered plasma is separated from whole blood donations.

Related Articles Read More >

FDA logo
FDA prevented 317 drug shortages in 2021
Pfizer-BioNTech vaccine vial
Pfizer, BioNTech moving forward on seeking COVID-19 vaccine EUA for youngest children
FDA logo
FDA curtails use of Janssen COVID-19 vaccine over blood clotting concerns
FDA logo
FDA sends warning letters to CBD and delta-8 THC product vendors

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards